Mark Chandy
Impact in
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- Chromatin Remodeling and Cancer
- Pluripotent Stem Cells Research
- Epigenetics and DNA Methylation
- Fungal and yeast genetics research
- Extracellular vesicles in disease
- Pharmacology top 10%
- Cannabis and Cannabinoid Research
Papers in
-
- Cannabis and Cannabinoid Research 5
-
- Genomics and Chromatin Dynamics 7
- Pluripotent Stem Cells Research 3
- Extracellular vesicles in disease 3
- Chromatin Remodeling and Cancer 3
- Co-authors
- Jerry L. Workman (6 shared papers)Joseph C. Wu (11 shared papers)Michael J. Carrozza (2 shared papers)Philippe Prochasson (2 shared papers)David T. Paik (3 shared papers)Scott C. Galasinski (1 shared paper)Ahmed H. Hassan (1 shared paper)Kristen E. Neely (1 shared paper)
- Journals
- Cell (3 papers)Clinical Science (2 papers)Pharmacological Reviews (1 paper)Science Translational Medicine (1 paper)Cardiovascular Toxicology (1 paper)
- Partner nations
- United StatesCanadaTaiwan
In The Last Decade
Mark Chandy
34 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 1k
- Pharmacology 87
- Cardiology and Cardiovascular Medicine 104
- Cancer Research 40
- Genetics 23
Countries citing papers authored by Mark Chandy
This map shows the geographic impact of Mark Chandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Chandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Chandy more than expected).
Fields of papers citing papers by Mark Chandy
This network shows the impact of papers produced by Mark Chandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Chandy. The network helps show where Mark Chandy may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Chandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 415 | |
| 2 | 2004 | 199 | |
| 3 | 2019 | 164 | |
| 4 | 2022 | 104 | |
| 5 | 2007 | 74 | |
| 6 | 2006 | 73 | |
| 7 | 2022 | 64 | |
| 8 | 2004 | 62 | |
| 9 | 2021 | 48 | |
| 10 | 2023 | 44 | |
| 11 | 2020 | 27 | |
| 12 | 2022 | 26 | |
| 13 | 2016 | 25 | |
| 14 | 2021 | 22 | |
| 15 | 2013 | 18 | |
| 16 | 2000 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2023 | 16 | |
| 19 | 2025 | 15 | |
| 20 | 2018 | 11 |
About Mark Chandy
Mark Chandy is a scholar working on Pharmacology, Molecular Biology, Cardiology and Cardiovascular Medicine, Genetics and Physiology, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (7 papers), Cannabis and Cannabinoid Research (5 papers), Pluripotent Stem Cells Research (3 papers), Extracellular vesicles in disease (3 papers), Chromatin Remodeling and Cancer (3 papers), Smoking Behavior and Cessation (2 papers), MicroRNA in disease regulation (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Molecular Biology (1k citations), Pharmacology (87 citations), Cardiology and Cardiovascular Medicine (104 citations), Cancer Research (40 citations) and Genetics (23 citations). Mark Chandy has collaborated with scholars based in United States, Canada and Taiwan. Frequent co-authors include Jerry L. Workman, Joseph C. Wu, Michael J. Carrozza, Philippe Prochasson, David T. Paik, Scott C. Galasinski, Ahmed H. Hassan, Kristen E. Neely, José Leonardo Gutiérrez and Dmitry Pokholok. Their work appears in journals such as Cell, Clinical Science, Pharmacological Reviews, Science Translational Medicine and Cardiovascular Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.